| Literature DB >> 26862916 |
Francis Raj Gandhi Amrit1, Elizabeth Marie Steenkiste1, Ramesh Ratnappan1, Shaw-Wen Chen2, T Brooke McClendon3, Dennis Kostka4, Judith Yanowitz3, Carissa Perez Olsen2, Arjumand Ghazi1.
Abstract
Elimination of the proliferating germline extends lifespan in C. elegans. This phenomenon provides a unique platform to understand how complex metazoans retain metabolic homeostasis when challenged with major physiological perturbations. Here, we demonstrate that two conserved transcription regulators essential for the longevity of germline-less adults, DAF-16/FOXO3A and TCER-1/TCERG1, concurrently enhance the expression of multiple genes involved in lipid synthesis and breakdown, and that both gene classes promote longevity. Lipidomic analyses revealed that key lipogenic processes, including de novo fatty acid synthesis, triglyceride production, desaturation and elongation, are augmented upon germline removal. Our data suggest that lipid anabolic and catabolic pathways are coordinately augmented in response to germline loss, and this metabolic shift helps preserve lipid homeostasis. DAF-16 and TCER-1 also perform essential inhibitory functions in germline-ablated animals. TCER-1 inhibits the somatic gene-expression program that facilitates reproduction and represses anti-longevity genes, whereas DAF-16 impedes ribosome biogenesis. Additionally, we discovered that TCER-1 is critical for optimal fertility in normal adults, suggesting that the protein acts as a switch supporting reproductive fitness or longevity depending on the presence or absence of the germline. Collectively, our data offer insights into how organisms adapt to changes in reproductive status, by utilizing the activating and repressive functions of transcription factors and coordinating fat production and degradation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26862916 PMCID: PMC4749232 DOI: 10.1371/journal.pgen.1005788
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Fig 1Identification of genes up regulated and downregulated by DAF-16 and TCER-1 following germline loss, and effects of their knockdown on lifespans of glp-1 mutants and wild-type worms, respectively.
A. Comparison of the transcriptomes of glp-1, daf-16;glp-1 and tcer-1;glp-1 day 2 adult mutants by RNA-Seq identified 685 genes whose expression is increased in glp-1 mutants (UP genes) by DAF-16 and/or TCER-1 (349 DAF-16-Specific UP targets, 213 TCER-1-Specific UP targets and 123 Joint UP targets) and 635 genes whose expression was repressed (DOWN genes: 196 DAF-16-Specific, 366 TCER-1-Specific and 73 Joint). B: DAVID analysis of DAF-16 and TCER-1 targets. The three UP groups (green) share an enrichment of lipid-metabolic genes (labeled in bold). Aging and lifespan regulation is another notable category enriched in DAF-16-Specific and Joint UP groups. The major GO category enriched in DAF-16-Specific DOWN group was translation (bold), whereas, growth, reproduction and aging were highly enriched in the TCER-1-Specific DOWN class. C: RNAi knockdown of UP and DOWN genes shortens glp-1 longevity and increases the lifespan of a wild-type surrogate strain fer-15;fem-1, respectively. The scatter-plot represents the combined results from knockdown of UP and DOWN genes. UP genes were inactivated by initiating RNAi from day 1 of adulthood in glp-1 mutants (green diamonds). The red triangles represent RNAi inactivation of TCER-1-Specific DOWN genes, from day 1 of adulthood, in the strain fer-15;fem-1 that has been used extensively as a surrogate for wild-type worms [16, 17]. The X-Axis depicts the fold-change in gene expression detected by RNA-Seq for each of the genes. The Y-Axis represents the percent effect on lifespan as compared to the strains grown on empty vector control. Data shown here is from experiments of Trial #1 in S3 and S8 Tables, and do not include joint DAF-16/TCER-1 targets (as they have two different fold-change values). See S3 and S8 Tables for detailed lifespan data.
Fig 2Key genes involved in lipid anabolism and catabolism are up regulated by DAF-16 and TCER-1 following germline loss.
A. Lipid Synthesis: Overview of reactions involved in fatty-acid synthesis initiation, desaturation and elongation, and the steps leading up to triglyceride (TAG) formation. Acetyl CoA molecules, through the combined activities of the enzymes encoded by pod-2, mlcd-1 and fasn-1 are converted to the saturated fatty-acid (SFA) Palmitate (C16:0). Palmitate can be converted to longer mono- and poly-unsaturated fatty acids (MUFAs and PUFAs, respectively) by elongase and desaturase enzymes (encoded by ‘elo’ and ‘fat’ genes, respectively). These free fatty acids (FFAs) are joined with glycerol 3-phosphate (Glycerol 3P) to form lysophosphatidic acid (LPA) and phosphatidic acid (PA). PA and monoglycerides (MAG) serve as substrates for formation of diglycerides (DAG). DAGs are converted to the neutral, storage lipid TAGs by action of diacylglycerol acyl transferase (DGAT) enzymes. DAGs are also used in phospholipid (PL) production. B. Lipid Breakdown: Lipid degradation commences with the hydrolysis of TAGs into DAGs through the activity of ATGL-1, and other lipases and lipase-like enzymes (encoded by the ‘lipl’ and ‘lips’ genes). The FFAs released as a result are broken down to Acetyl CoA through peroxisomal- and mitochondrial- β-oxidation. Genes predicted to encode enzymes involved at different steps of these pathways are shown. ACO: acetyl CoA oxidase; ACS: acetyl CoA synthase; ACDH: acetyl CoA dehydrogenase; ECH: enoyl CoA hydratase; HACD: hydroxy acyl CoA dehydrogenase. Genes that were identified in the RNA-Seq analysis as DAF-16 and/or TCER-1 targets are highlighted in colored boxes as follows: DAF-16-Specific (yellow), TCER-1-Specific (orange) and Joint (blue). Genes up regulated by these proteins (UP) are written in green, whereas, DOWN targets are represented in red. Genes that were predicted to undergo opposite regulation by DAF-16 and TCER-1 are shown in olive boxes. Notably, pod-2, mlcd-1 and 4/6 genes encoding DGAT enzymes were identified as UP targets. K07B1.4 was not picked up by RNA-Seq but is highlighted because it was previously identified as a common target of DAF-16 and TCER-1 [24].
Fig 3de novo fatty-acid synthesis is elevated following germline loss by DAF-16.
A, B. DAF-16 mediates increased expression of pod-2 and mlcd-1 at least in part in germline-less adults. mRNA levels of pod-2 (A) and mlcd-1 (B) compared between wild-type (N2, gray), glp-1 (green), daf-16;glp-1 (red) and tcer-1;glp-1 (orange) day 2 adults by Q-PCR. C-F. Germline loss causes increased de novo lipid synthesis in a daf-16-dependent manner. C, D. de novo fatty acid synthesis and dietary fat absorption and compared using a 13C isotope fatty-acid labeling assay [45] between late L4/early day 1 adults of wild type (N2, gray bars) and glp-1 (green) strains. de novo lipid synthesis is significantly increased in both neutral lipid (C) and phospholipid (D) fractions of glp-1 mutants. E, F. Day 2 adults of the sterile strains, glp-1 (green), daf-16;glp-1 (red) and tcer-1;glp-1 (orange), were assessed through the same assay. In both neutral lipids (E) and phospholipids (F), de novo lipid synthesis is substantially reduced in daf-16;glp-1 mutants, but not tcer-1;glp-1 mutants, as predicted by RNA-Seq and Q-PCR. G-I. Knockdown of de novo fatty-acid synthesis genes impairs the longevity of glp-1 adults. G. Effect of fasn-1 mutation on the lifespan of glp-1 mutants and wild-type (N2) worms. glp-1 (green; m = 26.5 ± 0.5, n = 76/85), fasn-1;glp-1 (pink; m = 18.0 ± 0.8, n = 84/88; P vs. glp-1 <0.0001), N2 (black; m = 16.7 ± 0.7, n = 76/91), fasn-1 (gray; m = 19.1 ± 0.6, n = 62/75; P vs. N2 <0.0001). H, I. Effect of RNAi knockdown of pod-2, fasn-1 (H) and mlcd-1 (I) on the lifespan of glp-1 mutants. glp-1 mutants were subjected to RNAi during adulthood by feeding bacteria containing empty control vector (green) as well as bacteria expressing dsRNA targeting different genes. In H: control (green; m = 27.9 ± 1.3, n = 49/50), daf-16 (red; m = 14.8 ± 0.3, n = 74/78; P vs. control <0.0001), tcer-1 (orange; m = 19.0 ± 0.6, n = 76/78; P vs. control <0.0001), pod-2 (blue, m = 19.8 ± 0.8, n = 61/63, P vs. control, <0.0001) and fasn-1 (pink, m = 18.5 ± 0.4, n = 69/72, P vs. control, <0.0001). In I: control (green; m = 23.3 ± 0.8, n = 77/91), daf-16 (red; m = 15.7 ± 0.3, n = 83/110; P vs. control <0.0001), tcer-1 (orange; m = 20.0 ± 0.7, n = 75/85; P vs. control <0.0001), mlcd-1 (pink; m = 20.6 ± 1.1, n = 53/75, P vs. control, 0.05). In A-F, asterisks represent the statistical significance of differences observed in an unpaired, two-tailed t-test with P values 0.05 (*), 0.005 (**) or < 0.0005 (***). Green asterisks indicate the comparison between N2 and glp-1, whereas, red and orange asterisks depict the comparisons between glp-1 and daf-16;glp-1 or tcer-1;glp-1, respectively. Error bars represent the standard error of the mean. Data from additional trials is shown in S6 (G) and S7H and S7I Tables.
Fig 4A. DAF-16 and TCER-1 mediate, in part, the increased expression of genes involved in triglyceride (TAG) production following germline removal. mRNA levels of genes encoding diacylglycerol acyl transferase (DGAT) enzymes that catalyze TAG production, compared relative to wild-type (N2, gray bar normalized to 1), between glp-1 (green), daf-16;glp-1 (red) and tcer-1;glp-1 (orange) day 2 adults by Q-PCR. B-J. daf-16;glp-1 mutants exhibit ectopic lipid deposition and undergo a progressive depletion of lipid stores with age. Lipid levels compared between different strains by ORO staining adults on days 2, 4 and 8 of adulthood. Representative images are shown in B-I and quantification is in J. The images focus on head region (B, D, F and H) and mid-body (C, E, G, I) of wild-type (N2, B, C) glp-1 (D, E), daf-16;glp-1 (F, G) and tcer-1;glp-1 (H, I) day 6 adults. daf-16;glp-1 mutants showed reduced ORO staining on day 2, as compared to glp-1. While N2 worms exhibit increased intestinal ORO after day 2, daf-16;glp-1 mutants continue to undergo reduction in ORO levels. They also exhibit large, ectopic lipid droplets in muscle cells that are not observed in other strains (compare arrowheads between F, G and other panels). J: daf-16;glp-1 mutants show decreased TAG levels.Using GC/MS, the triglyceride: phospholipid (TAG/PL) ratio of day 2 daf-16;glp-1 adults was found to be significantly lesser than that of age-matched glp-1 animals. tcer-1;glp-1 mutants did not exhibit reduction in ORO staining nor biochemical TAG depletion, despite promoting the upregulation of DGAT genes. In A, J and K, asterisks represent the statistical significance of differences observed in an unpaired, two-tailed t-test with P values 0.05 (*), 0.005 (**) or < 0.0005 (***). Green asterisks indicate the comparison between N2 and glp-1 whereas, red and orange asterisks depict the comparisons between glp-1 and daf-16;glp-1 or tcer-1;glp-1, respectively. The gray asterisks in J (day 4, N2 bar) show the comparison between N2 ORO levels on days 2 vs. 4. Error bars represent the standard error of the mean.
Fig 5DGAT-2 and ACS-22 exhibit redundant and diet-dependent effects on the longevity and lipid content of germline-less mutants.
A. RNAi inactivation ‘dgat’ genes shortens glp-1 mutants longevity modestly. glp-1 mutants were subjected to RNAi during adulthood by feeding bacteria containing empty control vector (green) or bacteria expressing dsRNA targeting ‘dgat’ genes. Control (green; m = 23.2 ± 0.3, n = 63/83), daf-16 (red; m = 15.2 ± 0.3, n = 79/79; P vs. control <0.0001), dgat-2 (pink; m = 18.5 ± 0.7, n = 71/80; P vs. control <0.0001), acs-22 (purple, m = 19.7 ± 1.3, n = 123/123, P vs. control, 0.006), Y53G8B.2 (blue, m = 20.7 ± 0.5, n = 59/71, P vs. control 0.02) and K07B1.4 (sand, m = 19.9 ± 1.0, n = 97/97, P vs. control, <0.0001). B, C. Effect of dgat-2(hj44) and acs-22(hj26) mutations on the lifespan of glp-1 mutants and wild-type (N2) worms on E. coli OP50. B. glp-1 (green; m = 26.5 ± 0.5, n = 76/85), dgat-2;glp-1 (pink; m = 28.5 ± 1.0, n = 52/61; P vs. glp-1 0.64), N2 (black; m = 16.7 ± 0.7, n = 76/91, P vs. glp-1 <0.0001), dgat-2 (gray; m = 22.6 ± 0.6, n = 75/88; P vs. N2 <0.0001). C: glp-1 (green; m = 21.0 ± 0.9, n = 92/96), acs-22;glp-1 (purple; m = 23.6 ± 0.6, n = 97/103; P vs. glp-1 0.87), N2 (black; m = 17.0 ± 0.7, n = 69/100), acs-22 (gray; m = 19.1 ± 0.5, n = 72/83; P vs. N2 0.1). Additional trials are shown in S6B and S6C and S7(A) Tables. D. Effect of dgat-2(hj44) and acs-22(hj26) mutations on the lifespan of glp-1 mutants grown during adulthood on E. coli HT115 with the empty control vector. N2 (black; m = 19.16 ± 0.5, n = 57/75), glp-1 (green; m = 24.2 ± 1.6, n = 43/60), dgat-2;glp-1 (pink; m = 16.3 ± 0.4, n = 87/98; P vs. glp-1 <0.0001), acs-22;glp-1 (purple; m = 15.7 ± 0.4, n = 75/86). E, F. Effect of dgat-2(hj44), acs-22(hj26) and fasn-1(fr8) mutations on fat levels of glp-1 mutants. Quantification of lipid levels compared between different strains through ORO staining on day 2 adults grown on E. coli OP50 (E) or E. coli HT115 (F). The mutations caused reduced ORO staining in both fertile and glp-1 backgrounds when grown on E. coli OP50. On E. coli HT115, dgat-2;glp-1 and acs-22;glp-1 did not show a significant ORO diminution. The box plots illustrate data from two biological replicates tested for each strain. Asterisks represent the P values {<0.05 (*), <0.005 (**) or <0.0001 (***)} derived using the multcomp package. See S6 Fig for ORO data of day 4 and 8 adults, and Methods for details of the statistical analyses.
Fig 6The expression of multiple lipases and fatty-acid β-oxidation genes is enhanced in germline-less adults through DAF-16 and TCER-1 activity.
A-E. Expression of lipases and lipase-related genes in germline-less adults. mRNA levels of lipl-1 (A), lipl-2 (B), lipl-5 (C), lips-10 (D) and lips-14 (E) compared between wild type (N2, gray), glp-1 (green), daf-16;glp-1 (red) and tcer-1;glp-1 (orange) day 2 adults by Q-PCR. F. Expression of multiple mitochondrial β-oxidation genes is elevated in glp-1 mutants, in part, by DAF-16, and by TCER-1. The heat map represents the combined results of Q-PCRs (conducted on the same stage as above) for genes predicted to function in mitochondrial β-oxidation. These genes were identified in RNA-Seq as UP genes and, as shown here, eight out of nine are increased in expression in glp-1 mutants. The increased expression levels are attenuated for seven of eight genes in daf-16;glp-1 mutants and for four of eight genes in tcer-1;glp-1 mutants. The color code is shown at the bottom of the panel. Green represents low levels of expression and red higher. Highest and smallest fold change values are indicated at each end of the color bar. In A-E, asterisks represent the statistical significance of the differences observed in an unpaired, two-tailed t-test with P values 0.05 (*), 0.005 (**) or < 0.0005 (***). Green asterisks indicate the comparison between N2 and glp-1 whereas, red and orange asterisks depict the comparisons between glp-1 and daf-16;glp-1 or tcer-1;glp-1, respectively. Error bars denote the standard error of the mean.
Genes repressed by TCER-1 following germline loss are predominantly required for optimal fertility in normal animals.
DAVID analysis and Gene Functional Classification of TCER-1-Specific DOWN revealed 53 genes in the group with the highest enrichment score (2.3). These are listed here along with their molecular identities and known human orthologs. See S4 Table for details of DAVID analyses and S5 Table for supporting data from REVIGO analysis. Many of these genes function in splicing and RNA processing (highlighted in bold). Strikingly, inactivation of 37/53 genes has been reported to elicit reproductive phenotypes enumerated here (70%, p<0.0001).
| TCER-1-Specific DOWN Gene Group 1 (Enrichment Score: 2.3) | |||
|---|---|---|---|
| Gene (Cosmid) | Molecular Function | Human Ortholog | Reproductive Defects Associated with Gene Reduction-of-Function |
| Splicing factor U2AF, RNA-binding protein | U2AF1: Small nuclear ribonucleoprotein auxiiary splicing factor | Sterility, multiple gonadal, vulval and germ-cell defects [ | |
| Yeast PRP (splicing factor)-related | XAB2: Pre-mRNA-splicing factor SYF1; PRPF6: Pre-mRNA-processing splicing factor 6 | Sterility, DTC defects [ | |
| Member of SR family of nuclear phosphoprotein splicing factors | SRSF11: Ser/Arg-rich splicing factor 11; SREK1: Glu/Lys-rich splicing regulatory protein 1 | Sterility | |
| RNP (RRM RNA binding) domain-containing protein; predicted to function in splicing | PUF60: Poly(U)-binding-splicing factor | Sterility, multiple vulval and germ-cell defects [ | |
| Cleavage and polyadenylation factor | PCF11: Pre-mRNA cleavage complex 2 protein | Sterility, multiple germ-cell defects [ | |
| Helicase | UAP56: Splicosome assembly protein; DDX39B: Spliceosome RNA helicase | Sterility, multiple vulval and germ-cell defects [ | |
| TIA1/TIAL RNA binding protein | TIAL1: TIA1 granule associated RNA-binding protein | Reduced brood size, sterility, vulval defects [ | |
| KH-domain protein involved in splicing and mRNA-export | QK1: KH domain RNA-binding and splicing protein, Quaking | Reduced brood size, vulval and egg-laying defects [ | |
| DEAH helicase, putative pre-mRNA-splicing factor | DHX15: Putative pre-mRNA-splicing factor ATP-dependent RNA helicase | Gonad and germline morphology defects, sterility [ | |
| RNA-binding domain | CCAR1: Cell division and apoptosis regulator protein 1 | Reduced brood size, vulval defects [ | |
| Shared homology with human putative RNA-binding protein | |||
| Alternatively spliced protein that in conjunction with LIN-35 and CLK-1 maintains large brood size and short lifespan, respectively | Reduced brood size [ | ||
| Novel protein required for osmosensation | Maternal sterile, vulval defects [ | ||
| Novel protein involved in developmental timing | Gonad and vulval morphology defects, egg-laying phentoypes, sterile progeny, long lifespan [ | ||
| Mitochondrial NADH ubiquinone oxidoreductase | NDUFA6: NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 6 | Sterility, long lifespan [ | |
| Mitochondrial Fe/S assembly protein | ISCA1: Iron-sulfur cluster assembly 1 | long lifespan [ | |
| Mitochondria-encoded large ribosomal protein | MRPL17: mitochondrial 39S ribosomal protein L17 | Sterility | |
| Mitochondria-encoded small ribosomal protein | MRPS5: 28S mitochondrial ribosomal protein S5 | Reduced brood size, long lifespan [ | |
| S-adenosyl methionine synthatase | MAT2A, MAT1A: S-adenosylmethionine synthases | Reduced brood size, sterility, vulval phenotypes, long lifespan [ | |
| S-adenosylmethionine synthetase | MAT2A, MAT1A: S-adenosylmethionine synthases | Vulval defects, sterile progeny [ | |
| Probable nucleolar GTPase involved in 60S ribosome synthesis | GTPB4: Nucleolar GTP-binding protein 1 | Multiple gonadal and germ cell defects, reduced brood size, sterility [ | |
| Cysteinyl tRNA synthetase | CARS: Cysteinyl tRNA synthetase | Sterility, gonadal and germ-cell defects [ | |
| Putative mitochondrial RNAse H | RNASEH1: Ribonuclease H1 | ||
| Protein arginine methyl transferase | PRMT1 and 8, HRMT1L2: protein arginine N-methyltransferase | Reduced brood size, vulval defects [ | |
| Polyunsaturated fatty acid (PUFA) elongase | ELOVL3 (Elongation of very long chain fatty acids) | ||
| Phospholipase | PLD4 and PLD5 (Phospholipases) | Reduced brood size, sterility [ | |
| O-acyl transferase | |||
| ASCC1: Activating Signal CoIntegrator Complex 1 | |||
| Nuclear pore complex protein | RANBP2: Sumo E3 ligase | Gonadal, vulval and germ-cel -defects, sterility, reduced brood size [ | |
| CEBPs: CCAAT/enhancer-binding proteins | Sterile progeny [ | ||
| Transport protein particle | TRAPPC11: Trafficking protein complex subunit 11 | Reduced brood size, sterility [ | |
| vessicle traffic protein syntaxin | STX16: Syntaxin 16 | ||
| DNAJ domain containing protein | DNAJC13, DnaJ homolog subfamily C member 13 | Reduced brood size, germ cell defects [ | |
| Monocarboxylate transporter 14 | |||
| Putative Cu transporter | SLC31A1: high affinity copper uptake protein 1 | Maternal sterile [ | |
| CEL: bile salt-activated lipase precursor Carboxylesterase 1 precursor | |||
| DNaJ domain protein | SEC63: Translocation protein | Sterile | |
| Glycogenin like protein | GYG1: Glycogenin1 | Reduced brood size, sterile progeny [ | |
| Spectraplakin | DST: Dystonin, MACF1 | Somatic gonadal, vulval defects and germ cell defects, reduced brood size, sterility [ | |
| Likely GTPase | LSG1: Large subunit GTPase | Sterility, vulval defects [ | |
| WAPAL: Isoform of Wings apart-like protein | Sterile | ||
| Prion-like-(Q/N-rich)- domain-bearing protein | |||
| Receptor tyrosine phosphatase in FGF pathway | PTPR: Receptor-type tyrosine-protein phosphatase | Reduced brood size, vulval defects, sterile progeny [ | |
| Intermediate filament organizer | |||
| NeuRonal IGCAM with immunoglobulin domain | CNTN2: Contactin | Germ cell defects, maternal sterile [ | |
| Myotactin | FN1: Fibronectin | Maternal sterile [ | |
| Reduced brood size, sterility, vulval defects [ | |||
| Uncharacterized protein | |||
| Aldose 1 Epimerase | GALM: Aldose 1 epimerase | ||
| Aldose 1 Epimerase | GALM: Aldose 1 epimerase | ||
| SERINC1: Serine incorporator 1 | |||
| Protein with domain of unknown function (DUF) | |||
| Uncharacterized protein | Germ cell defects, maternal sterile [ | ||
^ Wormbase curation reports reproductive defects in mutants generated by knock-out consortia (www.wormbase.org)
*Gene inactivation increases lifespan of normal adults
Fig 7TCER-1 promotes reproductive health in normal, fertile worms and metabolic homeostasis and longevity in germline-less animals.
A-C. tcer-1 mutants exhibit multiple fertility defects. Reproductive fitness parameters compared between wild type (N2, gray), daf-16 (red) and tcer-1 (orange) mutants, including fecundity (number of eggs laid, A), viability (percent of laid eggs that hatch successfully, B), oocyte production (C) grown at 20°C. tcer-1, but not daf-16, mutants are defective in all aspects and these phenotypes are aggravated further at 25°C (S4C Fig). D-F. tcer-1 mutants make defective sperm and oocytes. Functionality of tcer-1 mutants’ sperm and oocytes was assessed by crossing tcer-1 males to wild-type (N2) hermaphrodites (vertical striped bars) and tcer-1 hermaphrodites to N2 males (diagonal striped bars), respectively. Reproductive health measures were compared against control N2 hermaphrodites and males crossed to each other (gray bars). Shown here are results for fecundity (D) viability of eggs (E) and oocyte production (F). G, H. tcer-1 mutants exhibit inadequate germ-cell development and germline heterochrony. DAPI stained germline of wild type (N2) day 1 adults germ cell nuclei organized in spatial-temporal gradient, whereas, gonads from tcer-1 mutants exhibit significantly reduced germ-cell number. Gonads are outlined with yellow, dotted lines and scale bar in both images is 20μM. Germline heterochrony in the mutants is revealed by the presence of sperm (green arrows) within the proliferating region of the gonad and not within the spermatheca (demarcated with a green dotted line) as seen in N2. Quantification of germline defects is shown in S4 Fig. In A-F, asterisks represent the statistical significance of differences observed in an unpaired, two-tailed t-test with P values 0.05 (*), 0.005 (**) or < 0.0005 (***) between N2 and tcer-1 (orange asterisks) or daf-16 (red asterisks). I-K. Schematic representation of the model proposed based on the findings of this study. Our results suggest mechanisms by which DAF-16 and TCER-1 help maintain metabolic homeostasis in response to changes in the reproductive status of the animal (I). In fertile animals, TCER-1 ensures reproductive fitness, likely by promoting germ-cell proliferation and successful sperm-to-oocyte production switch in synchrony with somatic development (J). When the germline is lost, as in the case of glp-1 mutants, TCER-1 undergoes a role-reversal and inhibits the somatic program of reproduction instead (K). TCER-1 also represses anti-longevity genes independently. DAF-16, on the other hand restrains translation by repressing ribosomal-gene expression (K). Additionally, DAF-16 and TCER-1 enhance the expression of genes involved in both lipid-anabolic and lipid-catabolic pathways (depicted in K) in adaptation to germline depletion. We posit that the simultaneous enhancement of these ostensibly antagonistic processes (a) allows the animal to retain metabolic homeostasis during the physiological flux caused by germline loss, and (b) enables the production of lipid signaling moieties and/or ligands for transcription factors whose activities ultimately advance longevity.